707 related articles for article (PubMed ID: 25667292)
21. Staging and treatment of oropharyngeal cancer in the human papillomavirus era.
Ward MJ; Mellows T; Harris S; Webb A; Patel NN; Cox HJ; Piper K; Ottensmeier CH; Thomas GJ; King EV
Head Neck; 2015 Jul; 37(7):1002-13. PubMed ID: 24753272
[TBL] [Abstract][Full Text] [Related]
22. Detailed Analysis of Clinicopathologic Factors Demonstrate Distinct Difference in Outcome and Prognostic Factors Between Surgically Treated HPV-Positive and Negative Oropharyngeal Cancer.
Iyer NG; Dogan S; Palmer F; Rahmati R; Nixon IJ; Lee N; Patel SG; Shah JP; Ganly I
Ann Surg Oncol; 2015 Dec; 22(13):4411-21. PubMed ID: 25801358
[TBL] [Abstract][Full Text] [Related]
23. Rethinking the 10-pack-year rule for favorable human papillomavirus-associated oropharynx carcinoma: A multi-institution analysis.
Broughman JR; Xiong DD; Moeller BJ; Contrera KJ; Prendes BL; Lamarre ED; Ku JA; Burkey BB; Woody NM; Joshi NP; Adelstein DJ; Geiger JL; Frenkel CH; Milas ZL; Brickman DS; Sumrall AL; Carrizosa DR; Greskovich JF; Koyfman SA; Ward MC
Cancer; 2020 Jun; 126(12):2784-2790. PubMed ID: 32167593
[TBL] [Abstract][Full Text] [Related]
24. Impact of American Joint Committee on Cancer Eighth Edition clinical stage and smoking history on oncologic outcomes in human papillomavirus-associated oropharyngeal squamous cell carcinoma.
Hawkins PG; Mierzwa ML; Bellile E; Jackson WC; Malloy KM; Chinn SB; Spector ME; Shuman AG; Stucken CL; McLean SA; Bradford CR; Prince ME; Carey TE; Worden FP; Swiecicki PL; Taylor JMG; Wolf GT; Eisbruch A; Casper KA
Head Neck; 2019 Apr; 41(4):857-864. PubMed ID: 30775826
[TBL] [Abstract][Full Text] [Related]
25. Nodal staging convergence for HPV- and HPV+ oropharyngeal carcinoma.
Ho AS; Luu M; Kim S; Tighiouart M; Mita AC; Scher KS; Mallen-St Clair J; Walgama ES; Lin DC; Nguyen AT; Zumsteg ZS
Cancer; 2021 May; 127(10):1590-1597. PubMed ID: 33595897
[TBL] [Abstract][Full Text] [Related]
26. Comparison of the Seventh and Eighth Edition of American Joint Committee on Cancer (AJCC) Staging for Selected and Nonselected Oropharyngeal Squamous Cell Carcinomas.
Vijayvargiya P; Trivedi S; Rupji M; Song H; Liu Y; Jiang R; Kaka AS; Chen GZ; Stokes W; Steuer C; Shin DM; Beitler JJ; Patel MR; Aiken A; Saba NF
Oncologist; 2022 Feb; 27(1):48-56. PubMed ID: 35305095
[TBL] [Abstract][Full Text] [Related]
27. Impact of cisplatin dose and smoking pack-years in human papillomavirus-positive oropharyngeal squamous cell carcinoma treated with chemoradiotherapy.
Oliva M; Huang SH; Xu W; Su J; Hansen AR; Bratman SV; Ringash J; Jang R; Cho J; Bayley A; Hope AJ; Chen E; Giuliani M; Waldron J; Weinreb I; Perez-Ordonez B; Chepeha D; Kim J; O Sullivan B; Siu LL; Spreafico A
Eur J Cancer; 2019 Sep; 118():112-120. PubMed ID: 31330486
[TBL] [Abstract][Full Text] [Related]
28. Prognostic value of pretreatment circulating neutrophils, monocytes, and lymphocytes in oropharyngeal cancer stratified by human papillomavirus status.
Huang SH; Waldron JN; Milosevic M; Shen X; Ringash J; Su J; Tong L; Perez-Ordonez B; Weinreb I; Bayley AJ; Kim J; Hope A; Cho BC; Giuliani M; Razak A; Goldstein D; Shi W; Liu FF; Xu W; O'Sullivan B
Cancer; 2015 Feb; 121(4):545-55. PubMed ID: 25336438
[TBL] [Abstract][Full Text] [Related]
29. Assessment of Survival Model Performance Following Inclusion of Epstein-Barr Virus DNA Status in Conventional TNM Staging Groups in Epstein-Barr Virus-Related Nasopharyngeal Carcinoma.
Li WZ; Wu HJ; Lv SH; Hu XF; Liang H; Liu GY; Lu N; Bei WX; Lv X; Guo X; Xia WX; Xiang YQ
JAMA Netw Open; 2021 Sep; 4(9):e2124721. PubMed ID: 34554238
[TBL] [Abstract][Full Text] [Related]
30. Stage I HPV-positive oropharyngeal cancer: Should all patients receive similar treatments?
Yoshida EJ; Luu M; Mallen-St Clair J; Mita AC; Scher KS; Lu DJ; Nguyen AT; Shiao SL; Ho AS; Zumsteg ZS
Cancer; 2020 Jan; 126(1):58-66. PubMed ID: 31536144
[TBL] [Abstract][Full Text] [Related]
31. Prognostic importance of radiologic extranodal extension in HPV-positive oropharyngeal carcinoma and its potential role in refining TNM-8 cN-classification.
Huang SH; O'Sullivan B; Su J; Bartlett E; Kim J; Waldron JN; Ringash J; de Almeida JR; Bratman S; Hansen A; Bayley A; Cho J; Giuliani M; Hope A; Hosni A; Spreafico A; Siu L; Chepeha D; Tong L; Xu W; Yu E
Radiother Oncol; 2020 Mar; 144():13-22. PubMed ID: 31710939
[TBL] [Abstract][Full Text] [Related]
32. Human papillomavirus and survival of patients with oropharyngeal cancer.
Ang KK; Harris J; Wheeler R; Weber R; Rosenthal DI; Nguyen-Tân PF; Westra WH; Chung CH; Jordan RC; Lu C; Kim H; Axelrod R; Silverman CC; Redmond KP; Gillison ML
N Engl J Med; 2010 Jul; 363(1):24-35. PubMed ID: 20530316
[TBL] [Abstract][Full Text] [Related]
33. Impact of Smoking on Outcomes of HPV-related Oropharyngeal Cancer Treated with Primary Radiation or Surgery.
Vawda N; Banerjee RN; Debenham BJ
Int J Radiat Oncol Biol Phys; 2019 Apr; 103(5):1125-1131. PubMed ID: 30513378
[TBL] [Abstract][Full Text] [Related]
34. Radiologic Extranodal Extension Portends Worse Outcome in cN+ TNM-8 Stage I Human Papillomavirus-Mediated Oropharyngeal Cancer.
Billfalk-Kelly A; Yu E; Su J; O'Sullivan B; Waldron J; Ringash J; Bartlett E; Perez-Ordonez B; Weinreb I; Bayley A; Bratman SV; Cho J; Giuliani M; Hope A; Hosni A; Kim J; Hansen AR; de Almeida J; Tong L; Xu W; Huang SH
Int J Radiat Oncol Biol Phys; 2019 Aug; 104(5):1017-1027. PubMed ID: 30953712
[TBL] [Abstract][Full Text] [Related]
35. Changing prognostic significance of tumor stage and nodal stage in patients with squamous cell carcinoma of the oropharynx in the human papillomavirus era.
Keane FK; Chen YH; Neville BA; Tishler RB; Schoenfeld JD; Catalano PJ; Margalit DN
Cancer; 2015 Aug; 121(15):2594-602. PubMed ID: 25873094
[TBL] [Abstract][Full Text] [Related]
36. Smoking cessation is associated with improved survival in oropharynx cancer treated by chemoradiation.
Platek AJ; Jayaprakash V; Merzianu M; Platek ME; Cohan DM; Hicks WL; Marimuthu SP; Winslow TB; Gupta V; Arshad H; Kuriakose MA; Dibaj S; Marshall JR; Reid ME; Warren GW; Singh AK
Laryngoscope; 2016 Dec; 126(12):2733-2738. PubMed ID: 27346612
[TBL] [Abstract][Full Text] [Related]
37. Refining prognostic stratification of human papillomavirus-related oropharyngeal squamous cell carcinoma: different prognosis between T1 and T2.
Lee S; Lee SW; Park S; Yoon SM; Park JH; Song SY; Ahn SD; Kim JH; Choi EK; Kim SS; Jung J; Kim YS
Radiat Oncol J; 2017 Sep; 35(3):233-240. PubMed ID: 29037027
[TBL] [Abstract][Full Text] [Related]
38. Tobacco exposure as a major modifier of oncologic outcomes in human papillomavirus (HPV) associated oropharyngeal squamous cell carcinoma.
Elhalawani H; Mohamed ASR; Elgohari B; Lin TA; Sikora AG; Lai SY; Abusaif A; Phan J; Morrison WH; Gunn GB; Rosenthal DI; Garden AS; Fuller CD; Sandulache VC
BMC Cancer; 2020 Sep; 20(1):912. PubMed ID: 32967643
[TBL] [Abstract][Full Text] [Related]
39. Application of the Eighth Edition American Joint Committee on Cancer Staging System for HPV-Related Oropharyngeal Cancer Treated With Transoral Robotic Surgery.
Badhey AK; Olson A; Kadakia S; Russo J; Ting P; Khalid M; Yao M; Teng MS; Genden EM; Miles BA; Chai RL
Laryngoscope; 2018 May; 128(5):1133-1139. PubMed ID: 28990700
[TBL] [Abstract][Full Text] [Related]
40. Treatment outcomes and survival following definitive (chemo)radiotherapy in HPV-positive oropharynx cancer: Large-scale comparison of DAHANCA vs PMH cohorts.
Lassen P; Huang SH; Su J; Waldron J; Andersen M; Primdahl H; Johansen J; Kristensen CA; Andersen E; Eriksen JG; Hansen CR; Alsner J; Lilja-Fisher J; Bratman SV; Ringash J; Kim J; Hope A; Spreafico A; de Almeida J; Xu W; O'Sullivan B; Overgaard J
Int J Cancer; 2022 Apr; 150(8):1329-1340. PubMed ID: 34792199
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
